Sign In

Barbara Weber

President and CEO at Tango Therapeutics

Barbara Weber is the President and CEO of Tango Therapeutics, a biotechnology company focused on precision oncology. She has held this position since September 2017, shortly after the company was founded by Third Rock Ventures. Under her leadership, Tango Therapeutics has developed novel cancer therapies based on the principle of synthetic lethality, aiming to target specific vulnerabilities in cancer cells.12

Educational Background and Early Career: Barbara Weber earned her Bachelor's degree in Chemistry from the University of Washington, followed by her Doctor of Medicine (M.D.) from the University of Washington School of Medicine. She completed her residency in internal medicine at Yale University and a fellowship in medical oncology at the Dana-Farber Cancer Institute. Before entering the biotechnology sector, she was a professor of medicine and genetics at the University of Pennsylvania, where she led research in cancer genetics.123

Professional Experience: Prior to her role at Tango Therapeutics, Weber served as Senior Vice President and Global Head of Oncology Translational Medicine at Novartis from 2009 to 2015 and as Vice President of Oncology Discovery and Translational Medicine at GlaxoSmithKline from 2005 to 2009. She has also been involved with various organizations in leadership roles, including serving on the boards of Revolution Medicines and FogPharma.123

Achievements and Contributions: Weber is recognized for her contributions to oncology and has been elected to several prestigious organizations, including the American Association of Physicians and the American Society for Clinical Investigation, where she served as president in 2005. Her work focuses on developing innovative treatments for cancer patients, addressing unmet needs within the field.123

Related Questions

What are Barbara Weber's key achievements at Tango Therapeutics?
How did Barbara Weber transition from academia to the biotech industry?
What is the significance of synthetic lethality in cancer treatment?
How has Barbara Weber's leadership impacted Tango Therapeutics' growth?
What are the main projects Barbara Weber is currently involved in?
Barbara Weber
Barbara Weber, photo 1
Barbara Weber, photo 2
Add to my network

Location

Boston, Massachusetts